Saturday 17 October 2026
Export HCA’s income statement to Excel — free account
HCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024. In the quarter to June 2026, revenue grew 8.73%, EPS grew 11.6%, free cash flow fell 63.6% and total debt rose 11.8%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for ten, operating cash flow growth for three.
457.58
10.92
−2.33%
Follow HCA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.47 | 16.45 | 16.27 | 13.05 |
P/S ratio |
1.33 | 1.46 | 1.39 | 1.10 | |
P/FCF ratio |
12.26 | 14.35 | 13.35 | 14.34 | |
P/Operating CF |
22.48 | 46.79 | 52.54 | 36.82 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.92 | 2.06 | 2.00 | 1.73 | |
EV/EBITDA |
9.39 | 9.98 | 9.75 | 8.50 | |
EV/Operating CF |
11.12 | 12.33 | 11.76 | 12.11 | |
EV/FCF |
17.63 | 20.26 | 19.29 | 22.46 | |
Quick Ratio |
0.64 | 0.73 | 0.64 | 0.77 | |
Current Ratio |
0.85 | 0.97 | 0.83 | 0.99 | |
Net Debt/EBITDA |
11.22 | 11.02 | 12.35 | 12.06 | |
Debt/Assets |
74.50% | 76.57% | 78.15% | 78.61% | |
Debt/Equity |
(20.62) | (16.78) | (16.13) | (15.49) | |
Asset Turnover |
1.25 | 1.26 | 1.26 | 1.27 | |
Operating CF/Net income |
2.69 | 1.26 | 1.24 | 1.37 | |
Capex/Depreciation |
(1.44) | (1.61) | (1.19) | (1.29) | |
Interest Coverage |
5.31 | 5.60 | 4.92 | 5.15 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
43.65% | 42.84% | 43.35% | 40.98% | |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.17 | 0.17 | |
Share Based Compensation of Revenue |
0.54% | 0.51% | 0.45% | 0.42% | |
Graham Net Nets |
(0.47) | (0.43) | (0.46) | (0.57) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
6.07% | 6.08% | 6.14% | 7.66% | |
Free Cash Flow Yield |
8.16% | 6.97% | 7.49% | 6.97% | |
Revenue per Share |
82.27 | 82.54 | 85.47 | 91.73 | |
Operating CF per Share |
18.96 | 9.98 | 9.01 | 10.59 | |
Capex per Share |
(5.53) | (6.30) | (5.00) | (5.58) | |
Free Cash Flow per Share |
13.43 | 3.68 | 4.00 | 5.01 | |
Cash per Share |
4.28 | 4.40 | 4.20 | 4.59 | |
Shareholders Equity per Share |
(9.27) | (11.72) | (13.32) | (14.55) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(9.27) | (11.72) | (13.32) | (14.55) | |
Free Cash Flow |
3,128.00 | 870.00 | 895.00 | 1,104.00 | |
Working Capital |
(2,611.00) | (567.00) | (3,206.00) | (122.00) | |
Capital Expenditures |
(1,288.00) | (1,489.00) | (1,119.00) | (1,231.00) | |
Net Current Asset Value |
(46,621.00) | (47,708.00) | (48,376.00) | (49,269.00) | |
EV/EBIT |
12.21 | 12.94 | 12.70 | 11.10 | |
Capex to Sales |
0.07 | 0.08 | 0.06 | 0.06 | |
Price to Operating Income |
8.49 | 9.16 | 8.79 | 7.08 | |
| Other line items | |||||
Average Receivables |
10,171.50 | 10,809.00 | 11,206.00 | 11,370.00 | |
Average Payables |
4,393.50 | 4,467.50 | 4,647.00 | 4,501.00 | |
Average Inventory |
1,755.00 | 1,695.00 | 1,737.50 | 1,727.00 | |
Average Assets |
59,603.00 | 60,116.50 | 60,624.00 | 61,393.00 | |
Average Common Equity |
(686.50) | (1,108.00) | (1,708.00) | (2,223.50) |
Columns are period end dates